Psoriasis guidelines provide updates on pharmacotherapy, guidance on special populations

New consensus guidelines for the management of plaque psoriasis include updates on pharmacotherapy options and the treatment of special populations such as children, pregnant women and their partners, nursing mothers, the elderly, and patients diagnosed with cancer, HIV, or hepatitis B or C.

Key Point: Biologics and other immunosuppressive agents are becoming more commonplace in North America and other parts of the world to treat severe plaque psoriasis. Treatment in India has been limited by available agents, and in some cases, cost and issues with monitoring. If methotrexate is used to treat psoriasis, it’s important to monitor liver function and to avoid liver toxicity. Many topical therapies are available for less severe forms of the disease.

The consensus statement, which was reviewed by the members of Canada’s National Psoriasis Foundation Medical Board, also discusses the use of tumor necrosis factor (TNF)-antagonists, the use of vaccinations, and elective surgery for these patients.

The prevalence of psoriasis in India is estimated to range from 0.44% to 2.8% based on various studies and regional differences, according to a report by Dogra et al in 2010 in the Indian Journal of Dermatology, Venereology and Leprology. The authors reported that psoriasis is 2 times more common in...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Dermatology, Pharmacology and tagged , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.